Original language | English |
---|---|
Pages (from-to) | 1110-1113 |
Number of pages | 4 |
Journal | Clinical Microbiology and Infection |
Volume | 29 |
Issue number | 9 |
DOIs |
|
State | Published - Sep 2023 |
Which trial do we need? Highly bioavailable oral β-lactams versus quinolones or trimethoprim-sulfamethoxazole for gram-negative bacteraemia
Steven Y.C. Tong*, Dafna Yahav, Nick Daneman
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate
2
Scopus
citations